Synthetic Biology Market to Reach USD 45.8 Billion by 2032
Compound annual growth rate (CAGR) of 23.5%, potentially reaching USD 45.8 billion by 2032. This exponential growth trajectory is driven by accelerating adoption across pharmaceuticals, agriculture, and industrial biotechnology sectors, fueled by breakthroughs in genetic engineering and declining DNA sequencing costs